Published in J Fam Pract on June 01, 2002
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis (2007) 1.68
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf (2009) 0.94
A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis. Ann Rheum Dis (2004) 0.94
Right ballpark, wrong base: assessing safety of NSAIDs. J Fam Pract (2002) 0.87
Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis. Mol Ther Nucleic Acids (2013) 0.85
The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis. BMC Musculoskelet Disord (2014) 0.77
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003? Inflammopharmacology (2003) 0.76
Review: Long Noncoding RNAs in the Regulation of Inflammatory Pathways in Rheumatoid Arthritis and Osteoarthritis. Arthritis Rheumatol (2016) 0.76
Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses. Open Access Rheumatol (2013) 0.75
Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc (2005) 3.23
Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology (2008) 3.11
Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol (2008) 2.14
Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology (2004) 1.88
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol (2005) 1.55
Grading the complexity of endoscopic procedures: results of an ASGE working party. Gastrointest Endosc (2011) 1.39
An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc (2008) 1.32
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. Clin Rheumatol (2008) 1.29
A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J (2003) 1.27
Age- and sex-specific yield of Barrett's esophagus by endoscopy indication. Gastrointest Endosc (2009) 1.17
A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases. J Clin Gastroenterol (2005) 1.14
Do indication and demographics for colonoscopy affect completion? A large national database evaluation. Eur J Gastroenterol Hepatol (2010) 1.10
A closer look at same-day bidirectional endoscopy. Gastrointest Endosc (2008) 1.02
The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty. J Pain Symptom Manage (2003) 0.95
Antimicrobial acrylic materials with in situ generated silver nanoparticles. J Biomed Mater Res B Appl Biomater (2011) 0.92
Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum (2002) 0.92
The budget impact of endoscopic screening for esophageal varices in cirrhosis. Gastrointest Endosc (2007) 0.92
Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis. Eur J Gastroenterol Hepatol (2002) 0.92
Identifying and reporting risk factors for adverse events in endoscopy. Part I: cardiopulmonary events. Gastrointest Endosc (2011) 0.92
Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. Am J Ther (2002) 0.89
Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc (2007) 0.89
A multicenter, prospective, randomized comparison of a novel signal transmission capsule endoscope to an existing capsule endoscope. Gastrointest Endosc (2013) 0.89
Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. Obstet Gynecol (2002) 0.87
Identifying and reporting risk factors for adverse events in endoscopy. Part II: noncardiopulmonary events. Gastrointest Endosc (2011) 0.87
Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery. Am J Ther (2002) 0.84
A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis. Arthritis Res Ther (2010) 0.83
The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial. J Clin Pharmacol (2003) 0.83
The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery. J Am Dent Assoc (2002) 0.83
Barrett's esophagus on repeat endoscopy: should we look more than once? Am J Gastroenterol (2008) 0.83
Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol (2002) 0.82
A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain. Anesthesiology (2002) 0.81
Valdecoxib does not impair platelet function. Am J Emerg Med (2002) 0.81
Acid-related upper endoscopy findings in patients with diabetes versus non-diabetic patients. Dig Dis Sci (2010) 0.79
Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen. Osteoarthritis Cartilage (2002) 0.78
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA. J Clin Pharmacol (2016) 0.75
In Memoriam: Lauren Battat Gerson, MD, MS. Gastrointest Endosc (2017) 0.75
Turn, Turn, Turn-it's time to turn over the reins at GIE. Gastrointest Endosc (2014) 0.75
Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update. Gastrointest Endosc (2017) 0.75
American pain society pain questionnaire and other pain measures in the assessment of osteoarthritis pain: a pooled analysis of three celecoxib pivotal studies. Am J Ther (2003) 0.75
Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial. Clin Rheumatol (2017) 0.75
VideoGIE - launch! Gastrointest Endosc (2013) 0.75
Multisociety guideline on reprocessing flexible GI endoscopes: 2016 update. Gastrointest Endosc (2017) 0.75